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UK	science,	post-Brexit		
	
James	Wilsdon	
Editorial	in	Science	Vol	355,	Issue	6331,	p.1243,	24	March	2017	(author’s	final	edit)	
	
Nine	months	since	the	British	vote	to	exit	the	European	Union	(“Brexit”),	the	UK	
science	community’s	initial	dismay	has	given	way	to	hard-boiled	determination	
to	limit	the	damage	it	will	do	to	universities	and	research.	On	29	March,	Prime	
Minister	Theresa	May	is	expected	to	give	formal	notification	of	the	UK’s	intention	
to	withdraw	under	Article	50	of	the	Lisbon	Treaty,	the	constitutional	basis	of	the	
EU.	This	will	set	in	motion	a	two-year	period	of	intense	negotiation	on	the	terms	
of	the	UK’s	divorce,	and	any	future	agreements	with	the	EU	–	with	research	just	
one	line	item	on	a	long	list	of	issues	to	be	resolved.	
	
The	timeframe	is	extremely	tight.	Serious	talks	are	unlikely	to	get	underway	until	
after	the	French	elections	in	May,	and	they	need	to	wrap	up	by	autumn	2018,	to	
allow	time	for	any	deal	to	be	ratified	by	the	European	Council	and	Parliament.		
	
The	UK	has	made	maintaining	research	links	with	the	EU	one	of	its	twelve	
negotiating	priorities,	but	discussions	of	how	to	achieve	this	may	not	start	until	
early	2018.	Many	specific	concerns	of	the	research	community,	such	as	the	free	
movement	of	highly	skilled	people,	are	bound	up	with	larger,	more	hotly-
contested	questions.	
	
When	science	does	get	its	moment	in	the	negotiating	spotlight,	five	priorities	
stand	out.	There	must	be	reassurance	for	EU	citizens	employed	in	UK	
universities	and	institutes	(around	15%	of	all	academic	staff)	that	they	will	
retain	the	right	to	live	and	work	in	the	UK.	A	flexible	visa	regime	must	be	in	place	
after	Brexit,	to	support	the	continued	flow	of	international	talent	in	and	out	of	
the	UK,	across	the	whole	research	base,	and	not	just	restricted	to	certain	high	
priority	fields.	Given	the	importance	of	EU	collaboration	–	and	the	UK’s	success	
in	securing	over	7	billion	euro	of	EU	research	funding	between	2007	and	2013	–	
the	UK	must	maintain	some	kind	involvement	in	EU	joint	research	after	2020,	
under	its	Ninth	Framework	Programme		even	if	on	an	associated	basis,	like	other	
non-EU	countries,	such	as	Israel.		
	
The	UK	government	must	replace	any	research	funding	lost	as	a	result	of	Brexit.	
Aspects	of	this	may	be	hard	to	quantify	but	the	recent	announcement	of	a	£4.7	
billion	(GBP)	uplift	in	the	overall	UK	budget	between	2017	and	2020	gives	some	
cause	for	optimism.	And	the	UK	must	maintain	access	to	important	EU	research	
facilities	and	technical	and	advisory	networks.	For	example,	it	emerged	in	late	
January	that	UK	withdrawal	from	the	European	Atomic	Energy	Community	
(Euratom)	would	be	an	unexpected	by-product	of	Brexit,	to	the	consternation	of	
the	energy	research	community.	A	solution	needs	to	be	found	that	allows	
continued	access	to	sources	of	expertise	or	regulatory	oversight	(such	as	
Euratom	and	the	European	Medicines	Agency),	which	can’t	easily	be	recreated	at	
a	national	level.		
	
	
Outside	of	the	Article	50	process,	UK	universities	and	research	funders	are	now	
exploring	opportunities	to	scale	up	international	collaboration.	This	could	
include	new	bilateral	agreements	with	the	United	States,	and	Commonwealth	
countries	such	as	Australia,	Canada,	India,	Singapore	and	New	Zealand.		
	
The	imminent	restructuring	of	the	UK	research	system	under	a	consolidated	
funding	agency	–	UK	Research	and	Innovation	–	and	new	funding	schemes	-	such	
as	the	£700	million	(GBP)	Newton	Fund	focused	on	emerging	economies,	and	the	
£1.5	billion	Global	Challenges	Research	Fund	–	could	become	the	foundations	of	
a	more	strategic	and	ambitious	approach	to	international	collaboration.	Large	
philanthropic	funders,	such	as	the	Wellcome	Trust,	may	also	want	to	play	a	role.		
	
However	the	Article	50	negotiations	play	out,	the	message	should	be	
unwavering:	the	UK	remains	a	fantastic	place	to	do	research,	and	will	continue	to	
play	its	part	in	the	collaborative	networks	that	are	so	vital	to	21st	century	
science.	
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